Skip to main content
Gazyva 1000 mg/40mL injection, solution, concentrate by Genentech, Inc.
Gazyva, 1000 mg/40mL, injection, solution, concentrate Drug class: CD20-directed Cytolytic Antibody. Available on prescription only. Listed by Genentech, Inc..
Prescription only

Gazyva

obinutuzumab

Listed by Genentech, Inc.

Strength
1000 mg/40mL
Form
Injection, Solution, Concentrate
Route
Intravenous
Class
CD20-directed Cytolytic Antibody

What it contains

  • Obinutuzumab 1000 mg/40mL

FDA record

Dosage form Injection, Solution, Concentrate
Route Intravenous
Drug class CD20-directed Cytolytic Antibody
Approval route BLA — biologic licence
NDC code 50242-070
FDA application BLA125486
RxNorm concept 1442693
Package sizes listed 2
Marketed since November 2013

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.